INTENSITY THERAPEUTICS, INC. - INTS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.569M
QoQ value delta ($000)
+$859K (+120.99%)
Implied price effect (QoQ)
+66.99%
Shares
Total shares
3,919,007
QoQ shares delta
+957,574 (+32.33%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (INTS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 17 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 266 649,084 0.0%
SAPIENT CAPITAL LLC 244 650,151 0.0%
Rothschild Wealth LLC 203 495,910 0.02%
GEODE CAPITAL MANAGEMENT, LLC 188 460,248 0.0%
Mesirow Financial Investment Management, Inc. 102 251,000 0.0%
Legacy Advisors, LLC 62 153,447 0.01%
Creative Planning 58 143,136 0.0%
STATE STREET CORP 55 136,200 0.0%
BROWN ADVISORY INC 53 130,000 0.0%
Corient Private Wealth LLC 41 100,000 0.0%
Stonebridge Financial Group, LLC 31 77,377 0.0%
NORTHERN TRUST CORP 30 75,543 0.0%
Warberg Asset Management LLC 28 69,000 0.0%
JANE STREET GROUP, LLC 25 62,755 0.0%
Sigma Planning Corp 23 56,432 0.0%
Virtu Financial LLC 20 48,722 0.0%
IHT Wealth Management, LLC 20 50,483 0.0%
EWA, LLC 16 41,354 0.0%
TWO SIGMA SECURITIES, LLC 14 34,829 0.0%
One Charles Private Wealth Services, LLC 13 31,800 0.0%
BLAIR WILLIAM & CO/IL 12 30,191 0.0%
UBS Group AG 10 25,397 0.0%
NewEdge Advisors, LLC 10 25,000 0.0%
Tower Research Capital LLC (TRC) 8 21,532 0.0%
Sassicaia Capital Advisers LLC 6 15,000 0.01%